Exane Derivatives’s Vanguard Morningstar Value ETF VTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-428
Closed -$63.2K 999
2022
Q1
$63.2K Buy
+428
New +$62.5K 0.02% 543
2021
Q4
Sell
-7,528
Closed -$1.02M 1047
2021
Q3
$1.02M Hold
7,528
0.24% 86
2021
Q2
$1.04M Buy
7,528
+3,655
+94% +$502K 0.24% 92
2021
Q1
$509K Buy
3,873
+1,523
+65% +$191K 0.15% 143
2020
Q4
$280K Buy
+2,350
New +$264K 0.08% 258

Other funds holding VTV

Exane Derivatives's VTV Position: Q2 2022 in Review

Exane Derivatives sold out of Vanguard Morningstar Value ETF (VTV) in Q2 2022, closing a stake of 428 shares — an estimated $63.2K sold.

Exane Derivatives first reported a position in VTV in Q4 2020 and held it in 5 quarters. The position peaked at $1.04M in Q2 2021. 1,658 funds tracked by Wall St. Rank hold VTV as of Q2 2022.

  • Exane Derivatives reported no remaining Vanguard Morningstar Value ETF position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 428 Vanguard Morningstar Value ETF shares in Q2 2022, an estimated $63.2K.
  • Exane Derivatives first reported a position in Vanguard Morningstar Value ETF in Q4 2020 and held it in 5 quarters.
  • Exane Derivatives's Vanguard Morningstar Value ETF position peaked at $1.04M in Q2 2021.
  • 1,658 funds tracked by Wall St. Rank held Vanguard Morningstar Value ETF as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.